Chromatin maintenance and dynamics in senescence: a spotlight on SAHF formation and the epigenome of senescent cells

Chromosoma

Volumn 123, Issue 5, 2014, Pages 423-436

  Corpet, Armelle ^a   Stucki, Manuel ^a  

^a UNIVERSITÄTSSPITAL ZÜRICH   (Switzerland)

Author keywords

Chromatin dynamics; H3.3; PML NBs; SAHF; Senescence

Indexed keywords

HETEROCHROMATIN; HISTONE;

ANIMAL; CELL AGING; CELL NUCLEUS; EPIGENETICS; GENETICS; HETEROCHROMATIN; HUMAN; METABOLISM;

ANIMALS; CELL AGING; CELL NUCLEUS; EPIGENOMICS; HETEROCHROMATIN; HISTONES; HUMANS;

EID: 84929515235     PISSN: 00095915     EISSN: 14320886     Source Type: Journal    
DOI: 10.1007/s00412-014-0469-6     Document Type: Review

References (118)

1. Acosta JC, O’Loghlen A, Banito A et al (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133:1006–1018
2. Adams PD (2007) Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging. Gene 397:84–93
3. Ahmad K, Henikoff S (2002) The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell 9:1191–1200
4. Aird KM, Zhang G, Li H et al (2013) Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep 3:1252–1265
5. Banumathy G, Somaiah N, Zhang R et al (2009) Human UBN1 is an ortholog of yeast Hpc2p and has an essential role in the HIRA/ASF1a chromatin-remodeling pathway in senescent cells. Mol Cell Biol 29:758–770
6. Barascu A, Le Chalony C, Pennarun GEL et al (2012) Oxidative stress induces an ATM-independent senescence pathway through p38 MAPK-mediated lamin B1 accumulation. EMBO J 31:1080–1094
7. Bartkova J, Rezaei N, Liontos M et al (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633–637
8. Belancio VP, Roy-Engel AM, Pochampally RR, Deininger P (2010) Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res 38:3909–3922
9. Berman BP, Weisenberger DJ, Aman JF et al (2011) Berman 2012 DNA hypermethylation cancer LADs. Nat Publ Group 44:40–46
10. Bernardi R, Pandolfi PP (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8:1006–1016
11. Bickmore WA, van Steensel B (2013) Genome architecture: domain organization of interphase chromosomes. Cell 152:1270–1284
12. Bodor DL, Rodríguez MG, Moreno N, Jansen LET (2012) Analysis of protein turnover by quantitative SNAP-based pulse-chase imaging. Curr Protoc Cell Biol Chapter 8:Unit8.8
13. Bracken AP, Kleine-Kohlbrecher D, Dietrich N et al (2007) The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev 21:525–530
14. Braig M, Lee S, Loddenkemper C et al (2005) Oncogene-induced senescence as an initial barrier in lymphoma development. Nat Cell Biol 436:660–665
15. Burgess RJ, Zhang Z (2013) Histone chaperones in nucleosome assembly and human disease. Nat Struct Mol Biol 20:14–22
16. Burke B, Stewart CL (2013) The nuclear lamins: flexibility in function. Nat Rev Mol Cell Biol 14:13–24
17. Catez F, Yang H, Tracey KJ et al (2004) Network of dynamic interactions between histone H1 and high-mobility-group proteins in chromatin. Mol Cell Biol 24:4321–4328
18. Chan HM (2005) The p400 E1A-associated protein is a novel component of the p53—p21 senescence pathway. Genes Dev 19:196–201
19. Chandra T, Narita M (2013) High-order chromatin structure and the epigenome in SAHFs. Nucleus 4:23–28
20. Chandra T, Kirschner K, Thuret J-Y et al (2012) Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation. Mol Cell 47:203–214
21. Chen Z, Trotman LC, Shaffer D et al (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nat Cell Biol 436:725–730
22. Chicas A, Wang X, Zhang C et al (2010) Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell 17:376–387
23. Chow C-M, Georgiou A, Szutorisz H et al (2005) Variant histone H3.3 marks promoters of transcriptionally active genes during mammalian cell division. EMBO Rep 6:354–360
24. Collado M, Serrano M (2010) Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10:51–57
25. Collado M, Gil J, Efeyan A et al (2005) Tumour biology: senescence in premalignant tumours. Nat Cell Biol 436:642
26. Coppe J-P, Patil CK, Rodier F et al (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6:e301
27. Corpet A, De Koning L, Toedling J et al (2010) Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer. EMBO J 30:480–493
28. Corpet A, Olbrich T, Gwerder M et al (2014) Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization. Cell Cycle 13
29. Costanzi C, Pehrson JR (1998) Histone macroH2A1 is concentrated in the inactive X chromosome of female mammals. Nature 393:599–601
30. Cruickshanks HA, McBryan T, Nelson DM et al (2013) Senescent cells harbour features of the cancer epigenome. Nat Cell Biol 15:1495–1506
31. David G (2012) Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers. Cancer Biol Ther 13:992–1000
32. Dawson MA, Bannister AJ, Göttgens B et al (2009) JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin. Nature 461:819–822
33. De Cecco M, Criscione SW, Peckham EJ et al (2013) Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements. Aging Cell 12:247–256
34. de Stanchina E, Querido E, Narita M et al (2004) PML is a direct p53 target that modulates p53 effector functions. Mol Cell 13:523–535
35. Deal RB, Henikoff JG, Henikoff S (2010) Genome-wide kinetics of nucleosome turnover determined by metabolic labeling of histones. Science 328:1161–1164
36. Delbarre E, Ivanauskiene K, Küntziger T, Collas P (2013) DAXX-dependent supply of soluble (H3.3-H4) dimers to PML bodies pending deposition into chromatin. Genome Research
37. Denchi EL, Attwooll C, Pasini D, Helin K (2005) Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland. Mol Cell Biol 25:2660–2672
38. Di Micco R, Fumagalli M, Cicalese A et al (2006) Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444:638–642
39. Di Micco R, Sulli G, Dobreva M et al (2011) Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol 13:292–302
40. Dimri GP, Lee X, Basile G et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92:9363–9367
41. Drane P, Ouararhni K, Depaux A et al (2010) The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev 24:1253–1265
42. Dreesen O, Chojnowski A, Ong PF et al (2013) Lamin B1 fluctuations have differential effects on cellular proliferation and senescence. J Cell Biol 200:605–617
43. Enukashvily NI, Donev R, Waisertreiger ISR, Podgornaya OI (2007) Human chromosome 1 satellite 3 DNA is decondensed, demethylated and transcribed in senescent cells and in A431 epithelial carcinoma cells. Cytogenet Genome Res 118:42–54
44. Ferbeyre G, de Stanchina E, Querido E et al (2000) PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 14:2015–2027
45. Feser J, Truong D, Das C et al (2010) Elevated histone expression promotes life span extension. Mol Cell 39:724–735
46. Filion GJ, van Bemmel JG, Braunschweig U et al (2010) Systematic protein location mapping reveals five principal chromatin types in drosophila cells. Cell 143:212–224
47. Freund A, Laberge RM, Demaria M, Campisi J (2012) Lamin B1 loss is a senescence-associated biomarker. Mol Biol Cell 23:2066–2075
48. Funayama R, Ishikawa F (2007) Cellular senescence and chromatin structure. Chromosoma 116:431–440
49. Funayama R, Saito M, Tanobe H, Ishikawa F (2006) Loss of linker histone H1 in cellular senescence. J Cell Biol 175:869–880
50. Goldberg AD, Banaszynski LA, Noh K-M et al (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140:678–691
51. Guelen L, Pagie L, Brasset E et al (2008) Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 453:948–951
52. Hake SB, Garcia BA, Duncan EM et al (2006) Expression patterns and post-translational modifications associated with mammalian histone H3 variants. J Biol Chem 281:559–568
53. Hansen KD, Timp W, Bravo HC et al (2011) Increased methylation variation in epigenetic domains across cancer types. Nat Publ Group 43:768–775
54. Hock R, Furusawa T, Ueda T, Bustin M (2007) HMG chromosomal proteins in development and disease. Trends Cell Biol 17:72–79
55. Ishov AM (2004) Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J Cell Sci 117:3807–3820
56. Ivanov A, Pawlikowski J, Manoharan I et al (2013) Lysosome-mediated processing of chromatin in senescence. J Cell Biol 202:129–143
57. Jiang P, Du W, Mancuso A et al (2013) Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 1–7
58. Jin C, Zang C, Wei G et al (2009) H3.3/H2A.Z double variant-containing nucleosomes mark “nucleosome-free regions” of active promoters and other regulatory regions. Nat Genet 41:941–945
59. Jones JYP, Jones PA (2012) Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 22:9–20
60. Kaplon J, Zheng L, Meissl K et al (2013) Kaplon 2013 pyruvate dehydrogenase senescence. Nature 498:109–112
61. Khuong-Quang D-A, Buczkowicz P, Rakopoulos P et al (2012) K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124:439–447
62. Kosar M, Bartkova J, Hubackova S et al (2011) Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16 ink4a. Cell Cycle 10:457–468
63. Kuilman T, Michaloglou C, Vredeveld LCW et al (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133:1019–1031
64. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS (2010) The essence of senescence. Genes Dev 24:2463–2479
65. Kurz DJ, Decary S, Hong Y, Erusalimsky JD (2000) Senescence-associated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 113(Pt 20):3613–3622
66. Lallemand-Breitenbach V, de The H (2010) PML nuclear bodies. Cold Spring Harb Perspect Biol 2, a000661
67. Liu X, McEachron TA, Schwartzentruber J, Wu G (2014) Histone H3 mutations in pediatric brain tumors. Cold Spring Harb Perspect Biol 6, a018689
68. Loyola A, Bonaldi T, Roche D et al (2006) PTMs on H3 variants before chromatin assembly potentiate their final epigenetic state. Mol Cell 24:309–316
69. Luciani JJ (2006) PML nuclear bodies are highly organised DNA-protein structures with a function in heterochromatin remodelling at the G2 phase. J Cell Sci 119:2518–2531
70. Luger K, Dechassa ML, Tremethick DJ (2012) New insights into nucleosome and chromatin structure: an ordered state or a disordered affair? Nat Rev Mol Cell Biol 13:436–447
71. Maehara K, Takahashi K, Saitoh S (2010) CENP-A reduction induces a p53-dependent cellular senescence response to protect cells from executing defective mitoses. Mol Cell Biol 30:2090–2104
72. Mallette FA, Gaumont-Leclerc M-F, Ferbeyre G (2007) The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 21:43–48
73. Martin N, Benhamed M, Nacerddine K et al (2011) Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence. EMBO J 31:95–109
74. Michaloglou C, Vredeveld LCW, Soengas MS et al (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nat Cell Biol 436:720–724
75. Mito Y, Henikoff JG, Henikoff S (2005) Genome-scale profiling of histone H3.3 replacement patterns. Nat Genet 37:1090–1097
76. Muñoz-Espín D, Cañamero M, Maraver A et al (2013) Programmed cell senescence during mammalian embryonic development. Cell 155:1104–1118
77. Narita M, Nũnez S, Heard E et al (2003) Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113:703–716
78. Narita M, Narita M, Krizhanovsky V et al (2006) A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126:503–514
79. Ng RK, Gurdon JB (2007) Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription. Nat Cell Biol 10:102–109
80. O’Sullivan RJ, Karlseder J (2012) The great unravelling: chromatin as a modulator of the aging process. Trends Biochem Sci 37:466–476
81. O’Sullivan RJ, Kubicek S, Schreiber SL, Karlseder J (2010) Reduced histone biosynthesis and chromatin changes arising from a damage signal at telomeres. Nat Struct Mol Biol 17:1218–1225
82. Pearson M, Carbone R, Sebastiani C et al (2000) PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 406:207–210
83. Peric-Hupkes D, Meuleman W, Pagie L et al (2010) Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol Cell 38:603–613
84. Rai TS, Adams PD (2011) Lessons from senescence: chromatin maintenance in non-proliferating cells. BBA - Gene Regul Mech 1–10
85. Rai TS, Puri A, McBryan T et al (2011) Human CABIN1 is a functional member of the human HIRA/UBN1/ASF1a histone H3.3 chaperone complex. Mol Cell Biol 31:4107–4118
86. Ratnakumar K, Duarte LF, LeRoy G et al (2012) ATRX-mediated chromatin association of histone variant macroH2A1 regulates globin expression. Genes Dev 26:433–438
87. Ray-Gallet D, Woolfe A, Vassias I et al (2011) Dynamics of histone H3 deposition in vivo reveal a nucleosome gap-filling mechanism for H3.3 to maintain chromatin integrity. Mol Cell 44:928–941
88. Reeves R (2001) Molecular biology of HMGA proteins: hubs of nuclear function. Gene 277:63–81
89. Rodier F, Campisi J (2011) Four faces of cellular senescence. J Cell Biol 192:547–556
90. Rogakou EP, Sekeri-Pataryas KE (1999) Histone variants of H2A and H3 families are regulated during in vitro aging in the same manner as during differentiation. Exp Gerontol 34:741–754
91. Sadaie M, Salama R, Carroll T et al (2013) Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence. Genes Dev 27:1800–1808
92. Salama R, Sadaie M, Hoare M, Narita M (2014) Cellular senescence and its effector programs. Genes Dev 28:99–114
93. Schwartzentruber J, Korshunov A, Liu X-Y, et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 1–7
94. Serrano M, Lin AW, McCurrach ME et al (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602
95. Shah PP, Donahue G, Otte GL et al (2013) Lamin B1 depletion in senescent cells triggers large-scale changes in gene expression and the chromatin landscape. Genes Dev 27:1787–1799
96. Shimi T, Butin-Israeli V, Adam SA et al (2011) The role of nuclear lamin B1 in cell proliferation and senescence. Genes Dev 25:2579–2593
97. Storer M, Mas A, Robert-Moreno A et al (2013) Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell 155:1119–1130
98. Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425–437
99. Suzuki T, Fujii M, Ayusawa D (2002) Demethylation of classical satellite 2 and 3 DNA with chromosomal instability in senescent human fibroblasts. Exp Gerontol 37:1005–1014
100. Talbert PB, Henikoff S (2010) Histone variants—ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol 11:264–275
101. Tilman G, Arnoult N, Lenglez S et al (2012) Cancer-linked satellite 2 DNA hypomethylation does not regulate Sat2 non-coding RNA expression and is initiated by heat shock pathway activation. Epigenetics 7:903–913
102. Toyama BH, Savas JN, Park SK et al (2013) Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell 154:971–982
103. Vernier M, Bourdeau V, Gaumont-Leclerc M-F et al (2011) Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev 25:41–50
104. Wen H, Li Y, Xi Y et al (2014) Wen 2014 ZMYD recognizes H3.3K36me3. Nature 508:263–268
105. Weyemi U, Lagente-Chevallier O, Boufraqech M et al (2011) ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence. Oncogene 31:1117–1129
106. Wilson VL, Jones PA (1983) DNA methylation decreases in aging but not in immortal cells. Science 220:1055–1057
107. Wirbelauer C (2005) Variant histone H3.3 is deposited at sites of nucleosomal displacement throughout transcribed genes while active histone modifications show a promoter-proximal bias. Genes Dev 19:1761–1766
108. Wong LH, Ren H, Williams E et al (2008) Histone H3.3 incorporation provides a unique and functionally essential telomeric chromatin in embryonic stem cells. Genome Res 19:404–414
109. Wu GW, Broniscer A et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Publ Group 1–3
110. Xue Y, Gibbons R, Yan Z et al (2003) The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci U S A 100:10635–10640
111. Ye X, Zerlanko B, Zhang R et al (2007) Definition of pRB- and p53-dependent and -independent steps in HIRA/ASF1a-mediated formation of senescence-associated heterochromatin foci. Mol Cell Biol 27:2452–2465
112. Young JI (2001) DNA methyltransferase inhibition in normal human fibroblasts induces a p21-dependent cell cycle withdrawal. J Biol Chem 276:19610–19616
113. Young JI (2003) Telomerase expression in normal human fibroblasts stabilizes DNA 5-methylcytosine transferase I. J Biol Chem 278:19904–19908
114. Young ARJ, Narita M, Ferreira M et al (2009) Autophagy mediates the mitotic senescence transition. Genes Dev 23:798–803
115. Zhang R, Poustovoitov MV, Ye X et al (2005) Formation of macroH2A-containing senescence-associated heterochromatin foci and senescence driven by ASF1a and HIRA. Dev Cell 8:19–30
116. Zhang R, Chen W, Adams PD (2007a) Molecular dissection of formation of senescence-associated heterochromatin foci. Mol Cell Biol 27:2343–2358
117. Zhang R, Liu S-T, Chen W et al (2007b) HP1 proteins are essential for a dynamic nuclear response that rescues the function of perturbed heterochromatin in primary human cells. Mol Cell Biol 27:949–962
118. Zhang W, Ji W, Yang J et al (2008) Comparison of global DNA methylation profiles in replicative versus premature senescence. Life Sci 83:475–480